SCYNEXIS, Inc. (SCYX) Resumes Phase III Dosing for Brexafemme After 19-Month FDA HoldMay 29, 2025Yahoo Finance
ORIC Pharmaceuticals, Inc. (ORIC) Secures $125M to Advance ORIC-944 Phase 3 TrialsMay 29, 2025Yahoo Finance
ORIC Pharmaceuticals, Inc. (ORIC) Secures $125M to Advance ORIC-944 Phase 3 TrialsMay 29, 2025Yahoo Finance
AmpliTech (AMPG) Secures FCC Certification for 5G ORAN Radios, Accelerating Private 5G Expansion in the USMay 29, 2025Yahoo Finance
